Latest biopharmaceuticals Stories
RALEIGH, N.C., April 17, 2015 /PRNewswire/ -- Contego Medical, the first and only provider of the Integrated Embolic Protection(TM) filter platform for angioplasty balloon and stent delivery
- Data analyses in relapsing MS highlight MRI outcomes and 'no evident disease activity' (NEDA) measure for Rebif® (interferon beta-1a) vs.
Debiopharm presents preclinical results for 2 anti-cancer targeted therapies Debio 1143 and Debio 1347 LAUSANNE, Switzerland, April 16, 2015 /PRNewswire/ -- Debiopharm International
- Experienced leader and expert clinician to deliver strong outcomes for patients in the areas of Neurology and Immunology ROCKLAND, Mass., April 1, 2015 /PRNewswire/ -- EMD
- Novartis returns Alisporivir (DEB025) to Debiopharm Group(TM) including all rights for HCV and other indications - LAUSANNE, Switzerland, January 12, 2015 /PRNewswire/ --
Debio 1450, oral/IV FabI inhibitor active against all Staphylococcus species has received fast track designation for ABSSSI (acute bacterial skin and skin structure infections) LAUSANNE, Switzerland,
DALLAS, December 11, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Breast Cancer - Pipeline Review, H2 2014" and "Adrenocortical Carcinoma (Adrenal Cortex Cancer) -
The company leverages its keen understanding of protein purification to achieve the highest purification standards and product quality LONDON, Dec.
- A person in a secondary role, specifically the second most important character (after the protagonist).